UPDATE | November 10, 2026

Integrated development and manufacturing for complex bioconjugation

  • MAIL

As bioconjugation expands beyond conventional antibody-drug conjugates into oligonucleotide, peptide, and other complex formats, process development, analytics, and GMP manufacturing need to stay aligned.


In this on-demand webinar, Jaeook James Kim, Ph.D., Associate Director of Bioconjugation Development at Samsung Biologics, shares how integrated development, manufacturing, analytical, and formulation capabilities at a single site support complex bioconjugation programs. The session covers experience across multiple conjugation technologies and a case example of process scale-up and transfer from laboratory development to GMP manufacturing.


Key highlights include:

  • Integrated development and manufacturing for cytotoxic and non-cytotoxic bioconjugates at a single site

  • Process scale-up from laboratory development to pilot and GMP manufacturing

  • Analytical, formulation, and CMC considerations across development

  • Discover how a single-site model can support a more seamless path from development to GMP manufacturing.

As bioconjugation expands beyond conventional antibody-drug conjugates into oligonucleotide, peptide, and other complex formats, process development, analytics, and GMP manufacturing need to stay aligned.


In this on-demand webinar, Jaeook James Kim, Ph.D., Associate Director of Bioconjugation Development at Samsung Biologics, shares how integrated development, manufacturing, analytical, and formulation capabilities at a single site support complex bioconjugation programs. The session covers experience across multiple conjugation technologies and a case example of process scale-up and transfer from laboratory development to GMP manufacturing.


Key highlights include:

  • Integrated development and manufacturing for cytotoxic and non-cytotoxic bioconjugates at a single site

  • Process scale-up from laboratory development to pilot and GMP manufacturing

  • Analytical, formulation, and CMC considerations across development

  • Discover how a single-site model can support a more seamless path from development to GMP manufacturing.

Share article

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required